EmboTrap II Clot Retriever for Acute Ischemic Stroke Cleared in Europe

Neuravi, a company out of Galway, Ireland, won the European CE Mark for its EmboTrap II Revascularization Device to treat acute ischemic stroke. The device is made to trap clots, deliver TICI 2b-3 reperfusion, and consistently grab onto the clot as it's removed from the patient.

Based on the original EmboTrap that came to market in Europe last year, the new device is intended to treat a greater range of clot lengths via a .021″ microcatheter.

"The EmboTrap platform has been a great addition to my clinical practice. In my first nine cases using the device, I was able to get TICI 2b-3 reperfusion in one pass. Now with the EmboTrap II, I've had comparably good results when treating longer occlusions," said Christian Taschner, M.D., professor of Radiology, University of Freiburg, Germany, in a press release. "In fact, in early evaluations of the EmboTrap II 5×33 at six centers, 16 of 17 cases resulted in TICI 2b-3 flow. The open design of the device helps trap clot inside and also makes it quite flexible, which is important when removing clot from the arteries of the brain."

Product page: emboTrap II…

Press release: Neuravi…

This post EmboTrap II Clot Retriever for Acute Ischemic Stroke Cleared in Europe appeared first on Medgadget.

http://ift.tt/2cQb3YN